However, the inclusion of various additional tumor models in in vivo imaging studies will be of interest, as different molecularly defined subtypes of GBM may show different levels of TSPO expression, and TSPO-targeted PET imaging might therefore be useful to non-invasively assess the latter [35,36]. Here, TSPO is linked to glioblastoma.